全球口周皮炎治療市場研究報告 - 2023 年至 2030 年的行業分析、規模、佔有率、成長、趨勢和預測

預計到2030 年，全球口周皮炎治療市場需求將從2022 年的6900 萬美元增至近1.2115 億美元，2023-2030 年的複合年成長率為7.29%。

口周皮炎是一種皮膚病，其特徵是在嘴巴、鼻子周圍出現紅色小疙瘩或丘疹，有時也會出現在眼睛周圍。它會引起瘙癢、燒灼感和輕度不適。口周皮炎的治療通常包括自我護理措施和醫療干涉相結合。

市場動態：

口周皮炎發病率的上升和人們對該疾病認知的提高推動了對有效治療方法的需求。口周皮炎對生活品質的影響、引起的不適和自我意識促使人們尋求治療方案。醫學研究的進步在推動市場發展方面起著至關重要的作用，因為正在進行的研究側重於了解病情和開發新的治療方法。皮膚科醫生和醫療保健專業人員的建議影響著市場，因為他們會診斷病情、開出治療處方並提供持續護理。患者的偏好和經歷也影響著市場，因為積極的治療效果和口碑推薦影響著尋求治療者的選擇。治療方案的療效和安全性是關鍵驅動因素，患者尋求的治療方案必須能有效減輕症狀、改善皮膚外觀，同時將副作用降至最低。皮膚病治療的監管框架和指導方針影響著市場，影響著特定治療方案的可用性和可及性。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構，評估全球層面的競爭吸引力。此外，這些工具還對全球口周皮炎治療市場的各個細分市場進行了全面評估。口周皮炎治療行業的成長和趨勢為本研究提供了全面的方法。

地區分析：

本部分涵蓋了地區前景，重點介紹了北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區口周皮炎治療市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。口周皮炎治療市場的主要參與者包括輝瑞公司、諾華國際股份公司、強生公司、羅氏控股股份公司、默克公司、葛蘭素史克公司、阿斯利康公司、賽諾菲公司、艾伯維公司、吉利德科學公司、百時美施貴寶公司、禮來公司、諾和諾德公司、安進公司、泰華製藥工業有限公司、百時美施貴寶公司、Teva Pharmaceutical Industries Ltd.、Bayer AG、Takeda Pharmaceutical Company Limited、Moderna, Inc.、Vertex Pharmaceuticals Incorporated、Regeneron Pharmaceuticals, Inc.、Biogen Inc.、Celgene Corporation、Astellas Pharma Inc.和Alexion Pharmaceuticals, Inc.本節全面介紹了競爭格局，包括各種戰略發展，如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品上市及其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可根據您的需求提供客製化報告。

目 錄

第1 章：前言

• 報告說明
  • 目標
  • 目標受眾
  • 獨特銷售主張(USP) 和產品
• 研究範圍
• 研究方法
  • 市場調研過程
  • 市場調研方法

第2 章：執行摘要

• 市場亮點
• 全球市場概況

第3 章：口周皮炎治療- 行業分析

• 簡介- 市場動態
• 市場驅動因素
• 市場阻礙因素
• 市場機會
• 行業趨勢
• 波特五力分析
• 市場吸引力分析
  • 按診斷分類的市場吸引力分析
  • 按治療方法分類的市場吸引力分析
  • 按最終用戶分類的市場吸引力分析
  • 市場吸引力分析：按地區

第四章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料製造商列表
  • 主要原料價格趨勢
• 潛在買家名單
• 行銷管道
  • 直接行銷
  • 間接行銷
  • 行銷管道發展趨勢

第5章：全球口周皮炎治療市場分析：按診斷分類

• 按診斷概述
• 歷史和預測數據
• 按診斷分析
• 皮膚活體組織切片
• 體格檢查
• 其他

第6章：全球口周皮炎治療市場分析：按治療方法分類

• 按治療方法概述
• 歷史和預測數據
• 按治療方法分析
• 抗生素
• 外用伊維菌素
• 免疫抑製劑
• 其他

第7 章：全球口周皮炎治療市場分析：按最終用戶分類

• 終端用戶概述
• 歷史和預測數據
• 按最終用戶分析
• 家庭護理
• 專科診所
• 醫院
• 其他

第8章：全球口周皮炎治療市場分析：按地區分類

• 地區展望
• 簡介
• 北美銷售分析
  • 概述、歷史和預測數據銷售分析
  • 北美洲按細分市場銷售分析
  • 北美地區各國銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 歐洲分部銷售分析
  • 歐洲各國銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測數據銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲各國銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測數據銷售分析
  • 中東和非洲各地區銷售分析
  • 中東和非洲各國銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東和非洲其他地區銷售分析

第九章: 口周皮炎治療公司的競爭格局

• 口周皮炎治療市場競爭
• 夥伴關係/合作/協議
• 合併與收購
• 新產品上市
• 其他發展

第10 章: 公司簡介

• 公司佔有率分析
• 市場集中率
• Pfizer Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Novartis International AG
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Johnson & Johnson
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Roche Holding AG
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Merck & Co. Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• GlaxoSmithKline plc
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• AstraZeneca plc
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Sanofi SA
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• AbbVie Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Gilead Sciences Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Bristol Myers Squibb Company
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Eli Lilly and Company
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Novo Nordisk A/S
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Amgen Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Teva Pharmaceutical Industries Ltd.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展

注：在公司概況中，財務細節和近期發展視情況而定，私營公司可能不包括在內。

The global demand for Perioral Dermatitis Treatment Market is presumed to reach the market size of nearly USD 121.15 MN by 2030 from USD 69 MN in 2022 with a CAGR of 7.29% under the study period 2023 - 2030.

Perioral dermatitis is a skin condition which is characterized by the presence of small, red bumps or papules around the mouth, nose, and sometimes the eyes. It can cause itching, burning, and mild discomfort. The treatment of perioral dermatitis typically involves a combination of self-care measures and medical interventions.

MARKET DYNAMICS:

The increasing prevalence of perioral dermatitis and greater awareness of the condition drive the demand for effective treatments. Its impact on quality of life, causing discomfort and self-consciousness, motivates individuals to seek treatment options. Advancements in medical research play a crucial role in driving the market as ongoing studies focus on understanding the condition and developing new treatment approaches. Recommendations from dermatologists and healthcare professionals influence the market as they diagnose the condition, prescribe treatments, and provide ongoing care. Patient preferences and experiences also shape the market, as positive outcomes and word-of-mouth recommendations influence the choices of individuals seeking treatment. The efficacy and safety of treatment options are key drivers, with individuals seeking treatments that have demonstrated effectiveness in reducing symptoms and improving skin appearance while minimizing side effects. Regulatory frameworks and guidelines for dermatological treatments impact the market, affecting the availability and accessibility of specific treatment options.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of perioral dermatitis treatment. The growth and trends of perioral dermatitis treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the perioral dermatitis treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnosis

• Skin Biopsy
• Physical Examination
• Others

By Treatment

• Antibiotics
• Topical Ivermectin
• Immunosuppressive Agents
• Others

By End-User

• Homecare
• Specialty Clinics
• Hospitals
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Perioral Dermatitis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Perioral Dermatitis Treatment market include Pfizer Inc., Novartis International AG, Johnson & Johnson, Roche Holding AG, Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, AbbVie Inc., Gilead Sciences, Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Amgen Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Moderna, Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc., Biogen Inc., Celgene Corporation, Astellas Pharma Inc., and Alexion Pharmaceuticals, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PERIORAL DERMATITIS TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Diagnosis
  • 3.7.2 Market Attractiveness Analysis By Treatment
  • 3.7.3 Market Attractiveness Analysis By End-User
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY DIAGNOSIS

• 5.1 Overview by Diagnosis
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Diagnosis
• 5.4 Skin Biopsy Historic and Forecast Sales by Regions
• 5.5 Physical Examination Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY TREATMENT

• 6.1 Overview by Treatment
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Treatment
• 6.4 Antibiotics Historic and Forecast Sales by Regions
• 6.5 Topical Ivermectin Historic and Forecast Sales by Regions
• 6.6 Immunosuppressive Agents Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-User
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-User
• 7.4 Homecare Historic and Forecast Sales by Regions
• 7.5 Specialty Clinics Historic and Forecast Sales by Regions
• 7.6 Hospitals Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PERIORAL DERMATITIS TREATMENT COMPANIES

• 9.1. Perioral Dermatitis Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF PERIORAL DERMATITIS TREATMENT INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Pfizer Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Novartis International AG
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Johnson & Johnson
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Roche Holding AG
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck & Co. Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. GlaxoSmithKline plc
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. AstraZeneca plc
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Sanofi SA
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. AbbVie Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Gilead Sciences Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Bristol Myers Squibb Company
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Eli Lilly and Company
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Novo Nordisk A/S
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. Amgen Inc.
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments
• 10.17. Teva Pharmaceutical Industries Ltd.
  • 10.17.1. Company Overview
  • 10.17.2. Company Revenue
  • 10.17.3. Products
  • 10.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Diagnosis (USD MN)
• Skin Biopsy Market Sales by Geography (USD MN)
• Physical Examination Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Treatment (USD MN)
• Antibiotics Market Sales by Geography (USD MN)
• Topical Ivermectin Market Sales by Geography (USD MN)
• Immunosuppressive Agents Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-User (USD MN)
• Homecare Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Perioral Dermatitis Treatment Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Perioral Dermatitis Treatment Report
• Market Research Process
• Market Research Methodology
• Global Perioral Dermatitis Treatment Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Diagnosis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by End-User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Diagnosis (USD MN)
• Skin Biopsy Market Sales by Geography (USD MN)
• Physical Examination Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Treatment (USD MN)
• Antibiotics Market Sales by Geography (USD MN)
• Topical Ivermectin Market Sales by Geography (USD MN)
• Immunosuppressive Agents Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-User (USD MN)
• Homecare Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.